The expression level of EphA1 and its association with clinical parameters are factors that have been analyzed for various tumors, including gastric cancer, colorectal cancer, non-melanoma skin cancer, and squamous cell carcinoma (32–35). Here, EPHA1 is linked to squamous cell carcinoma.